Literature DB >> 11046139

p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4.

S J Miller1, T Suthiphongchai, G P Zambetti, M E Ewen.   

Abstract

One consequence of transforming growth factor beta (TGF-beta) treatment is inhibition of Cdk4 synthesis, and this is dependent on p53. Here, we show that the 5' untranslated region (UTR) of the cdk4 mRNA is both necessary and sufficient for wild-type p53-dependent TGF-beta-regulated translational inhibition of cdk4. Wild-type p53 bound selectively to the 5' UTR of the cdk4 mRNA and inhibited translation of RNAs that contain this region. RNA binding and translational control are two genetically separable functions of p53, as are specific and nonspecific RNA binding. Moreover, transactivation-defective mutants of p53 retain the ability to regulate cdk4 translation. Our findings suggest that p53 functions as a regulator of translation in response to TGF-beta in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046139      PMCID: PMC102149          DOI: 10.1128/MCB.20.22.8420-8431.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

Review 1.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

2.  Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.

Authors:  M Laiho; J A DeCaprio; J W Ludlow; D M Livingston; J Massagué
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

3.  Cytoplasmic p53 polypeptide is associated with ribosomes.

Authors:  B M Fontoura; C A Atienza; E A Sorokina; T Morimoto; R B Carroll
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

4.  Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.

Authors:  A Iavarone; J Massagué
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

5.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage.

Authors:  A Samad; R B Carroll
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

7.  Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.

Authors:  M L Zapp; S Stern; M R Green
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

8.  p53 is covalently linked to 5.8S rRNA.

Authors:  B M Fontoura; E A Sorokina; E David; R B Carroll
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

9.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.

Authors:  S Shirodkar; M Ewen; J A DeCaprio; J Morgan; D M Livingston; T Chittenden
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  31 in total

1.  Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein.

Authors:  Takao Fukuda; Megumi Ashizuka; Takanori Nakamura; Kotaro Shibahara; Katsumasa Maeda; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Takeshi Uchiumi
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Authors:  M A Parker; N G Deane; E A Thompson; R H Whitehead; S K Mithani; M K Washington; P K Datta; D A Dixon; R D Beauchamp
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

Review 3.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

4.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

5.  Exonucleolytic degradation of RNA by p53 protein in cytoplasm.

Authors:  Mary Bakhanashvili; Rachel Gedelovich; Shai Grinberg; Galia Rahav
Journal:  J Mol Med (Berl)       Date:  2007-08-15       Impact factor: 4.599

Review 6.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

7.  Analysis of p53-RNA interactions in cultured human cells.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  Biochem Biophys Res Commun       Date:  2007-09-10       Impact factor: 3.575

8.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

9.  SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.

Authors:  Cian J Lynch; Zahid H Shah; Simon J Allison; Shafiq U Ahmed; Jack Ford; Lorna J Warnock; Han Li; Manuel Serrano; Jo Milner
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 10.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.